BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 38062114)

  • 21. Atypical teratoid rhabdoid tumor: improved long-term survival with an intensive multimodal therapy and delayed radiotherapy. The Medical University of Vienna Experience 1992-2012.
    Slavc I; Chocholous M; Leiss U; Haberler C; Peyrl A; Azizi AA; Dieckmann K; Woehrer A; Peters C; Widhalm G; Dorfer C; Czech T
    Cancer Med; 2014 Feb; 3(1):91-100. PubMed ID: 24402832
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent progress and novel approaches to treating atypical teratoid rhabdoid tumor.
    Alva E; Rubens J; Chi S; Rosenberg T; Reddy A; Raabe EH; Margol A
    Neoplasia; 2023 Mar; 37():100880. PubMed ID: 36773516
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predisposition to atypical teratoid/rhabdoid tumor due to an inherited INI1 mutation.
    Janson K; Nedzi LA; David O; Schorin M; Walsh JW; Bhattacharjee M; Pridjian G; Tan L; Judkins AR; Biegel JA
    Pediatr Blood Cancer; 2006 Sep; 47(3):279-84. PubMed ID: 16261613
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rhabdoid tumor predisposition syndrome.
    Sredni ST; Tomita T
    Pediatr Dev Pathol; 2015; 18(1):49-58. PubMed ID: 25494491
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel Strategy Involving High-Dose Chemotherapy with Stem Cell Rescue Followed by Intrathecal Topotecan Maintenance Therapy without Whole-Brain Irradiation for Atypical Teratoid/Rhabdoid Tumors.
    Yamada A; Kinoshita M; Kamimura S; Jinnouchi T; Azuma M; Yamashita S; Yokogami K; Takeshima H; Moritake H
    Pediatr Hematol Oncol; 2023; 40(7):629-642. PubMed ID: 37519026
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nonsense mutation and inactivation of SMARCA4 (BRG1) in an atypical teratoid/rhabdoid tumor showing retained SMARCB1 (INI1) expression.
    Hasselblatt M; Gesk S; Oyen F; Rossi S; Viscardi E; Giangaspero F; Giannini C; Judkins AR; Frühwald MC; Obser T; Schneppenheim R; Siebert R; Paulus W
    Am J Surg Pathol; 2011 Jun; 35(6):933-5. PubMed ID: 21566516
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rhabdoid tumour: a malignancy of early childhood with variable primary site, histology and clinical behaviour.
    Wu X; Dagar V; Algar E; Muscat A; Bandopadhayay P; Ashley D; Wo Chow C
    Pathology; 2008 Dec; 40(7):664-70. PubMed ID: 18985520
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinicopathologic prognostic factors in childhood atypical teratoid and rhabdoid tumor of the central nervous system: a multicenter study.
    Dufour C; Beaugrand A; Le Deley MC; Bourdeaut F; André N; Leblond P; Bertozzi AI; Frappaz D; Rialland X; Fouyssac F; Edan C; Grill J; Quidot M; Varlet P
    Cancer; 2012 Aug; 118(15):3812-21. PubMed ID: 22180295
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spontaneous Regression of Atypical Teratoid Rhabdoid Tumor Without Therapy in a Patient With Uncommon Regional Inactivation of SMARCB1 ( hSNF5/INI1).
    Peterson JEG; Bavle A; Mehta VP; Rauch RA; Whitehead WE; Mohila CA; Su JM; Adesina AM
    Pediatr Dev Pathol; 2019; 22(2):161-165. PubMed ID: 30470167
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Loss of expression of SMARCA4 (BRG1), SMARCA2 (BRM) and SMARCB1 (INI1) in undifferentiated carcinoma of the endometrium is not uncommon and is not always associated with rhabdoid morphology.
    Ramalingam P; Croce S; McCluggage WG
    Histopathology; 2017 Feb; 70(3):359-366. PubMed ID: 27656868
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rhabdoid tumors: integrating biological insights with clinical success: a report from the SMARCB1 and Rhabdoid Tumor Symposium, Paris, December 12-14, 2013.
    Bourdeaut F; Chi SN; Frühwald MC
    Cancer Genet; 2014 Sep; 207(9):346-51. PubMed ID: 25468731
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Secondary INI1-deficient rhabdoid tumors of the central nervous system: analysis of four cases and literature review.
    Nobusawa S; Nakata S; Yoshida Y; Yamazaki T; Ueki K; Amano K; Yamamoto J; Miyahara M; Sugai T; Nakazato Y; Hirato J; Yokoo H
    Virchows Arch; 2020 May; 476(5):763-772. PubMed ID: 31707588
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of nuclear export restores nuclear localization and residual tumor suppressor function of truncated SMARCB1/INI1 protein in a molecular subset of atypical teratoid/rhabdoid tumors.
    Pathak R; Zin F; Thomas C; Bens S; Gayden T; Karamchandani J; Dudley RW; Nemes K; Johann PD; Oyen F; Kordes U; Jabado N; Siebert R; Paulus W; Kool M; Frühwald MC; Albrecht S; Kalpana GV; Hasselblatt M
    Acta Neuropathol; 2021 Aug; 142(2):361-374. PubMed ID: 34003336
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors.
    Biegel JA; Zhou JY; Rorke LB; Stenstrom C; Wainwright LM; Fogelgren B
    Cancer Res; 1999 Jan; 59(1):74-9. PubMed ID: 9892189
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathology and diagnosis of SMARCB1-deficient tumors.
    Margol AS; Judkins AR
    Cancer Genet; 2014 Sep; 207(9):358-64. PubMed ID: 25246033
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunohistochemical expression of embryonic stem cell markers in malignant rhabdoid tumors.
    Deisch J; Raisanen J; Rakheja D
    Pediatr Dev Pathol; 2011; 14(5):353-9. PubMed ID: 21417895
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary atypical teratoid/rhabdoid tumor of central nervous system in children: a clinicopathological analysis and review of literature in China.
    Yang M; Chen X; Wang N; Zhu K; Hu YZ; Zhao Y; Shu Y; Zhao ML; Gu WZ; Tang HF
    Int J Clin Exp Pathol; 2014; 7(5):2411-20. PubMed ID: 24966951
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Atypical teratoid/ rhabdoid tumor, an immunohistochemical study of potential diagnostic and prognostic markers.
    Al-Hussaini M; Dissi N; Souki C; Amayiri N
    Neuropathology; 2016 Feb; 36(1):17-26. PubMed ID: 26207291
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Renal medullary carcinoma: rhabdoid features and the absence of INI1 expression as markers of aggressive behavior.
    Cheng JX; Tretiakova M; Gong C; Mandal S; Krausz T; Taxy JB
    Mod Pathol; 2008 Jun; 21(6):647-52. PubMed ID: 18327209
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synchronous Central Nervous System Atypical Teratoid/Rhabdoid Tumor and Malignant Rhabdoid Tumor of the Kidney: Case Report of a Long-Term Survivor and Review of the Literature.
    Abu Arja MH; Patel P; Shah SH; Auletta JJ; Meyer EK; Conley SE; Aldrink JH; Pindrik JA; AbdelBaki MS
    World Neurosurg; 2018 Mar; 111():6-15. PubMed ID: 29223518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.